222 results on '"Meagher, Margaret F."'
Search Results
2. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry
3. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
4. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group
5. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR
6. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
7. MP36-06 COMBINATION OF CHARLSON COMORBIDITY INDEX AND C-REACTIVE PROTEIN IS ASSOCIATED WITH IMPROVED PROGNOSTIC PERFORMANCE COMPARED TO CHARLSON COMORBIDITY INDEX ALONE IN RENAL CELL CARCINOMA
8. MP35-08 MAPPING SOCIOECONOMIC DISPARITIES: ANALYZING RADICAL CYSTECTOMY OUTCOMES IN SAN DIEGO COUNTY
9. MP51-09 COMPARATIVE EFFICACY OF CKD-EPI 2012 AND 2021 EQUATIONS FOR PREDICTION OF SURVIVAL OUTCOMES FOLLOWING RENAL SURGERY: ANALYSIS OF THE INMARC REGISTRY
10. PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS
11. MP01-07 IMPACT OF CHEMOTHERAPY ON ANXIETY, DEPRESSION, AND SUICIDALITY AMONGST TESTICULAR CANCER SURVIVORS
12. MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN
13. PD20-06 COMPARATIVE ANALYSIS OF NEOADJUVANT VERSUS ADJUVANT THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN THE SETTING OF CLINICAL NODE POSITIVE DISEASE: ANALYSIS OF THE ROBUUST REGISTRY
14. MP36-05 NODESAFE NOMOGRAM: A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE INVOLVEMENT AT THE TIME OF NEPHRECTOMY OR NODAL RECURRENCE IN NON-METASTATIC RENAL CELL CARCINOMA
15. MP67-03 IMPACT OF NUMBER OF INNER AND OUTER RENORRAPHY STITCHES ON FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
16. MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
17. MP67-16 PREOPERATIVE ESTIMATION MODEL FOR PATHOLOGICAL T3 UPSTAGING IN PATIENTS WITH CLINICAL T1-2 CLEAR CELL RENAL CELL CARCINOMA UNDERWENT SURGERY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC)
18. MP38-03 PREDICTORS AND OUTCOME OF LYMPH NODE INVOLVEMENT FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR PRIMARY UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
19. MP36-10 UNRAVELING THE “OBESITY PARADOX” IN RENAL CORTICAL TUMORS: INSIGHTS FROM THE INMARC REGISTRY
20. MP08-04 RELIABILITY AND PRELIMINARY VALIDATION OF A BODY IMAGE SCALE SURVEY INSTRUMENT FOR USE IN BLADDER CANCER PATIENTS
21. MP67-20 OPEN SURGERY VS MINIMALLY INVASIVE SURGERY FOR RENAL CELL CARCINOMA: A PROPENSITY-SCORE-MATCHING COMPARISON OF FUNCTIONAL OUTCOMES
22. MP38-18 DECISIONAL AND PROGNOSTIC IMPACT OF DIAGNOSTIC URETEROSCOPY IN HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COLLABORATIVE ANALYSIS (ROBUUST COLLABORATIVE GROUP)
23. MP44-09 PROGNOSTIC NOMOGRAMS INCORPORATING PREOPERATIVE CRP LEVEL FOR PREDICTING SURVIVAL OUTCOMES IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CELL CARCINOMA: INMARC STUDY
24. MP01-16 MOLECULAR DRIVERS OF ORGANOTROPISM AND CISPLATIN RESISTANCE IN GERM CELL TUMORS
25. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
26. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry
27. C-REACTIVE PROTEIN KINETICS ARE ASSOCIATED WITH PROGRESSION AND SURVIVAL IN SURGICALLY TREATED RENAL CELL CARCINOMA PATIENTS
28. IMPACT OF OBESITY ON SURGICALLY-INDUCED RENAL FUNCTIONAL DECLINE FOLLOWING RADICAL AND PARTIAL NEPHRECTOMY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC) DATABASE
29. DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
30. COMPARATIVE ANALYSIS OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN PT3AN0M0 RENAL CELL CARCINOMA: A MULTICENTER PROPENSITY SCORE-MATCHED ANALYSIS
31. SHIFTING THE PARADIGM: THE INTRIGUING ROLE OF C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM -ANALYSIS OF THE INMARC REGISTRY
32. DEVELOPMENT OF NODESAFE A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE METASTASIS OR RECURRENCE AT THE TIME OF OR FOLLOWING NEPHRECTOMY.
33. ROLE OF RADICAL CYSTECTOMY IN MANAGEMENT OF BLADDER CANCER WITH CLINICAL EVIDENCE OF REGIONAL LYMPH NODE INVOLVEMENT AT US VETERANS HEALTH ADMINISTRATION FACILITIES
34. HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHRECTOMY FOR RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC REGISTRY
35. DEVELOPMENT OF A NOVEL NOMOGRAM TO PREDICT BENIGN LESION PATHOLOGY IN PATIENTS AFFECTED BY RENAL MASSES: ANALYSIS OF THE INMARC REGISTRY.
36. INCORPORATING C-REACTIVE PROTEIN INTO THE TRIFECTA: IMPLICATIONS FOR SURVIVAL AND FUNCTIONAL OUTCOMES FOLLOWING PARTIAL NEPHRECTOMY
37. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
38. Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis
39. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis
40. Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma
41. Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
42. PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy
43. Microbiomes in Post–Digital Rectal Exam Urine Samples are Linked to Prostate Cancer Risk
44. Should partial nephrectomy be considered “elective” in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy
45. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.
46. Comparative analysis of outcomes of neoadjuvant and adjuvant systemic therapy in non-metastatic renal cell carcinoma: A propensity score-matched analysis from the INMARC registry.
47. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)
48. Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review.
49. PD07-11 PARTIAL VERSUS RADICAL NEPHRECTOMY FOR COMPLEX RENAL MASS: MULTICENTER COMPARATIVE ANALYSIS OF FUNCTIONAL OUTCOMES (ROSULA COLLABORATIVE GROUP)
50. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.